According to the report titled ‘Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025’, available with MarketStudyReport, global pediatric vaccines market is expected to amass a valuation of USD 15 billion during the period 2018-2025.
 

Widespread public awareness of the pediatric diseases, mass acceptance of vaccines, and increased government emphasis on immunization programs & drives are factors propelling the growth of global pediatric vaccines market.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/1114670/
 

Moreover, massive federal funding on the research & development of vaccines is likely to further accelerate the industry progress during the forecast period.
 

Besides this, the document discusses the restrains that may cause the augmentation of the industry to hamper during the period 2018-2025. It also mentions the opportunities available to the businesses in this domain to garner lucrative returns during the projected timeframe. 
 

It further outlines the segments of the market by enumerating information about the market share held by each vertical and also projects the year-on-year growth anticipated through the year 2025.
 

The study on global pediatrics vaccines industry depicts historic data from 2010-2017 as well as makes projections for the period 2018-2025, by assessing factors such as the number of children vaccinated during the timeframe.
 

It further elaborates on the leading vaccines such as Measles Mumps & Rubella (MMR), Varicella / Chicken Pox, Rotavirus, Diphtheria Tetanus & Pertussis (DTaP), Haemophilus Influenzae Type B (HIB), Hepatitis A, Polio, Hepatitis B, Pneumococcal, and Influenza Pediatric among others.
 

Moving on, the report enlists the prominent players in global pediatric vaccines market such as Sanofi Pasteur, Grifols S.A., Merck & Co. Inc., GlaxoSmithKline (GSK) plc, and Pfizer Inc. among others. These companies are evaluated based on their portfolios, revenue earnings, development stages of the vaccines, and market share held. It highlights the future roadmap by analyzing key trends affecting the business outlook.